Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial

International Journal of Stroke

Volumn 10, Issue 3, 2015, Pages 449-451

  Bath, Philip M W ^a   Robson, Katie ^a   Woodhouse, Lisa J ^a   Sprigg, Nikola ^a   Dineen, Robert ^a   Pocock, Stuart ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Acute ischemic stroke; Acute TIA; Aspirin; Bleeding; Clopidogrel; Dipyridamole; Randomized controlled trial; Recurrence; Statistical analysis plan

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FUNDING; HUMAN; INTERVENTION STUDY; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVENTION STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; RECURRENCE RISK; RECURRENT DISEASE; SECONDARY PREVENTION; SHORT COURSE THERAPY; STATISTICAL ANALYSIS; TRANSIENT ISCHEMIC ATTACK; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; INTERNATIONAL COOPERATION; MALE; MULTICENTER STUDY; STROKE;

ASPIRIN; BRAIN ISCHEMIA; DIPYRIDAMOLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; STROKE; TICLOPIDINE;

EID: 84924813756     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12445     Document Type: Article

References (27)

1. Rothwell PM, Giles MF, Chandratheva A etal. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet Neurol 2007; 370:1432-1442.
2. Lavallee PC, Meseguer E, Abboud H etal. A transient ischaemic attach clinic with round-the-clock access (SOS0TIA): feasibility and effects. Lancet Neurol 2007; 6:953-960.
3. International Stroke Trial Collaborative Group. The International Stroke Trial (IST); a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349:1569-1581.
4. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20, 000 patients with acute ischaemic stroke. Lancet 1997; 349:1641-1649.
5. Geeganage CM, Diener H-C, Algra A etal. Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack stroke, 2012. 43.
6. Wang Y, Wang Y, Zhao X etal. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013; 369:11-19.
7. Wong KSL, Wang Y, Leng X etal. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation 2013; 128:1656-1666.
8. Zhao L, Bath P, Heptinstall S. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. Br J Pharmacol 2001; 134:353-358.
9. Scholz T, Zhao L, Temmler U, Bath P, Heptinstall S, Losche W. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro. Platelets 2002; 13:401-406.
10. Zhao L, Bath PMW, Fox S etal. The effects of GPII-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Curr Med Res Opin 2003; 19:178-186.
11. Zhao L, Fletcher S, Weaver C etal. Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and lecokyte function in normal volunteers and patients with prior ischaemic stroke. Thromb Haemost 2005; 93:527-534.
12. Zhao L, Gray LJ, Leonardi-Bee J, Weaver CS, Heptinstall S, Bath PM. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in nformal volunteers and patients with prior ischaemic stroke. Platelets 2006; 17:100-104.
13. Sprigg N, Gray LJ, England T etal. A randomised controlled trial of triple antiplatelet therapy (Aspirin, Clopidogrel and Dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility (ISRCTN 83673558). PLoS ONE 2008; 3:e2852.
14. Willmot M, Zhao L, Heptinstall S, Bath PMW. Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke. J Stroke Cerebrovasc Dis 2004; 13:138-140.
15. Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet 2001; 357:373-380.
16. Bath P, Houlton A, Woodhouse L, Sprigg N, Wardlaw J, Pocock S. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. Int J Stroke 2014; 9:372-374.
17. Bath PMW, Geeganage CM, Gray LJ, Collier T, Pocock S. Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published stroke trials. Stroke 2008; 39:2817-2823.
18. Bath PM, Geeganage C, Gray LJ. Ordinal reanalysis of the SHEP trial. Stroke 2008; 39:e145.
19. The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? Statistical re-analysis of functional outcomes in stroke trials. Stroke 2007; 38:1911-1915.
20. The Optimising Analysis of Stroke Trials (OAST) Collaboration. Calculation of sample size for stroke trials assessing functional outcome: comparison of binary and ordinal approaches. Int J Stroke 2008; 3:78-84.
21. The Optimising Analysis of Stroke Trials (OAST) Collaboration. Should stroke trials adjust functional outcome for baseline prognostic factors? Stroke 2009; 40:888-894.
22. Weir CJ, Lees KR. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. Stat Med 2003; 22:705-726.
23. Bath PM, Lees KR, Schellinger PD etal. Statistical analysis of the primary outcome in acute stroke trials. Stroke 2012; 43:1171-1178.
24. (NICE) NIfHaCE. Clopidogrel and modifiedrelease dipyridamole in the prevention of occlusive vascular events National Institute for Health and Clincal Excellence, 2005.
25. Ali M, Bath PMB, Davis SM etal. The virtual international stroke trials archive (VISTA). Stroke 2007; 38:1905-1910.
26. Sandercock PA, Niewada M, Czlonkowska A. The international stroke trial database. Trials 2011; 12:101.
27. Wardlaw J, Bath P, Sandercock P etal. The NeuroGrid stroke examplar clinical trial protocol. Int J Stroke 2007; 2:63-69.